成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 89711-08-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 89711-08-0
Chemical Structure| 89711-08-0
Structure of 89711-08-0 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 89711-08-0 ]

Related Doc. of [ 89711-08-0 ]

Alternatived Products of [ 89711-08-0 ]
Product Citations

Product Details of [ 89711-08-0 ]

CAS No. :89711-08-0 MDL No. :MFCD01321273
Formula : C7H13NO3 Boiling Point : -
Linear Structure Formula :(CH3)3COCONHCH2CHO InChI Key :ACNRTYKOPZDRCO-UHFFFAOYSA-N
M.W : 159.18 Pubchem ID :4247255
Synonyms :

Calculated chemistry of [ 89711-08-0 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.71
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.48
TPSA : 55.4 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.94 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.62
Log Po/w (XLOGP3) : 0.46
Log Po/w (WLOGP) : 0.71
Log Po/w (MLOGP) : 0.19
Log Po/w (SILICOS-IT) : 0.28
Consensus Log Po/w : 0.65

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.79
Solubility : 26.0 mg/ml ; 0.163 mol/l
Class : Very soluble
Log S (Ali) : -1.19
Solubility : 10.2 mg/ml ; 0.0643 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.17
Solubility : 10.7 mg/ml ; 0.0671 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.77

Safety of [ 89711-08-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 89711-08-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 89711-08-0 ]

[ 89711-08-0 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 369-26-6 ]
  • [ 89711-08-0 ]
  • methyl 3-((2-((tert-butoxycarbonyl)amino)ethyl)amino)-4-fluorobenzoate [ No CAS ]
YieldReaction ConditionsOperation in experiment
Methyl 3-((2-((tert-butoxycarbonyl)amino)ethyl)amino)-4-fluorobenzoate (I-44)Methyl 3-amino-4-fluorobenzoate (8.4 mmol) and tert-butyl (2-oxoethyl)carbamate (12.6 mmol) were dissolved in MeOH (100 ml_) and AcOH (10 ml_). After stirring for 1 hr at room temperature the reaction mixture was treated with NaCNBH3(16.6 mmol) and stirred for 2 hrs. After removal of solvent (aspirator) the mixture was dissolved in EtOAc and washed with NaHC03(sat., 1x). The aqueous phase was washed with EtOAc (1x) and the combined organic layers were dried (MgSO^. The product (I-44) was taken on crude for the next step. 1H NMR (400 MHz, CDCl3): delta 7.40-7.38 (m, 2H), 7.02 (dd, J = 8.8 Hz, 11 .1 , 1 H), 4.88 (s, 1 H), 3.91 (s, 3H), 3.40-3.38 (m, 4H), 1.47 (s, 9H). MS (m/z): 313.1 (M+H)+.
  • 2
  • tert-butyl (1-bromopropan-2-yl)carbamate [ No CAS ]
  • [ 89711-08-0 ]
  • [ 89830-98-8 ]
  • tert-butyl N-[2-[[2-(4-cyclopropylimidazol-1-yl)-1-methylethyl]amino]ethyl]carbamate [ No CAS ]
  • tert-butyl N-[2-[[2-(5-cyclopropylimidazol-1-yl)-1-methylethyl]amino]ethyl]carbamate [ No CAS ]
YieldReaction ConditionsOperation in experiment
Potassium hydroxide (73.9 mg, 1.3 177 mmol%) and tert-butyl N-[(2R)-2-bromopropyl]carbamate (230.1mg, 0.96634 mmol) are added to a solution of <strong>[89830-98-8]4-cyclopropyl-1H-imidazole</strong> (100 mg, 0.087849 mmol) in DMSO (2 mL) at 0 C. The mixture is stirred at room temperature for 65 hours. The reaction is quenched with water and extracted with EtOAc (3x). The organic extracts are washed with saturated NaC1 (3x), dried over Na2SO4, filtered, and concentrated to dryness. The residue is purified bysilica gel flash chromatography with 4% MeOH in DCM to give the title compounds as a mixture of 2 regioisomers (112 mg, 22.82%) and as a yellow oil. ES/MS (m/z): 266 (M+ 1). TFA (2 mL, 26.45 mmol) is added to racemic tert-butyl N-[2-(4-cyclopropylimidazol- i-yl)-i -methyl-ethyl] carbamate and to racemic tert-butyl N- [2-(5 -cyclopropylimidazol-1-yl)-1-methyl-ethyl]carbamate (112 mg, 0.2005 mmol) in DCM(10 mL) at room temperature. The mixture is stirred at room temperature for 1 hour andis concentrated to give the crude title compounds as a mixture of regioisomers (69.8 mg,100%) as a yellow oil. ES/MS (m/z): 166 (M+1). Sodium triacetoxyborohydride (56.9 mg, 0.260 mmol) is added to a solution of racemi c-i -(4-cyclopropylimidazol -1 -yl)propan-2-amine and racemic- 1 -(5- cyclopropylimidazol- 1 -yl)propan-2-amine (69.7 mg, 0.200 mmol) and tert-butyl N-(2- oxoethyl)carbamate (33.6 mg, 0.200 mmol) in DCM (5 mL) and acetic acid (15.6 mg, 0.260 mmol) at room temperature. The mixture is stirred at room temperature for 18 hours. The reaction is quenched by the addition of saturated NaHCO3. The mixture is extracted with DCM (3x), the organic extracts are dried over Na2SO4, filtered, and concentrated to give the crude title compound as a mixture of regioisomers (130 mg, 100%) as a yellow oil. ES/MS (m/z): 309 (M+1).
  • 3
  • tert-butyl (1-bromopropan-2-yl)carbamate [ No CAS ]
  • [ 89711-08-0 ]
  • [ 89830-98-8 ]
  • 1-[2-(4-cyclopropylimidazol-1-yl)-1-methylethyl]imidazolidin-2-one [ No CAS ]
  • 1-[2-(5-cyclopropylimidazol-1-yl)-1-methylethyl]imidazolidin-2-one [ No CAS ]
YieldReaction ConditionsOperation in experiment
Potassium hydroxide (73.9 mg, 1.3 177 mmol%) and tert-butyl N-[(2R)-2-bromopropyl]carbamate (230.1mg, 0.96634 mmol) are added to a solution of <strong>[89830-98-8]4-cyclopropyl-1H-imidazole</strong> (100 mg, 0.087849 mmol) in DMSO (2 mL) at 0 C. The mixture is stirred at room temperature for 65 hours. The reaction is quenched with water and extracted with EtOAc (3x). The organic extracts are washed with saturated NaC1 (3x), dried over Na2SO4, filtered, and concentrated to dryness. The residue is purified bysilica gel flash chromatography with 4% MeOH in DCM to give the title compounds as a mixture of 2 regioisomers (112 mg, 22.82%) and as a yellow oil. ES/MS (m/z): 266 (M+ 1). TFA (2 mL, 26.45 mmol) is added to racemic tert-butyl N-[2-(4-cyclopropylimidazol- i-yl)-i -methyl-ethyl] carbamate and to racemic tert-butyl N- [2-(5 -cyclopropylimidazol-1-yl)-1-methyl-ethyl]carbamate (112 mg, 0.2005 mmol) in DCM(10 mL) at room temperature. The mixture is stirred at room temperature for 1 hour andis concentrated to give the crude title compounds as a mixture of regioisomers (69.8 mg,100%) as a yellow oil. ES/MS (m/z): 166 (M+1). Sodium triacetoxyborohydride (56.9 mg, 0.260 mmol) is added to a solution of racemi c-i -(4-cyclopropylimidazol -1 -yl)propan-2-amine and racemic- 1 -(5- cyclopropylimidazol- 1 -yl)propan-2-amine (69.7 mg, 0.200 mmol) and tert-butyl N-(2- oxoethyl)carbamate (33.6 mg, 0.200 mmol) in DCM (5 mL) and acetic acid (15.6 mg, 0.260 mmol) at room temperature. The mixture is stirred at room temperature for 18 hours. The reaction is quenched by the addition of saturated NaHCO3. The mixture is extracted with DCM (3x), the organic extracts are dried over Na2SO4, filtered, and concentrated to give the crude title compound as a mixture of regioisomers (130 mg, 100%) as a yellow oil. ES/MS (m/z): 309 (M+1).
  • 4
  • [ 89711-08-0 ]
  • [ 121148-00-3 ]
  • 1-tert-butyl 2-methyl (2S,4R)-4-[2-(tert-butoxycarbonylamino)ethylamino]pyrrolidine-1,2-dicarboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
42% Acetic acid (42 pL, 0.73 mmcl) was added to a solution of 1 -(tert-butyl) 2-methyl (2S,4R)-4-aminopyrrolidine- 1 ,2-dicarboxylate (7.48 g, 30.6 mmcl) and tert-butyl (2-oxoethyl)carbamate (4.64 g, 29.2 mmcl) in MeOH (194 mL) and the reaction stirred at roomtemperature for 3 h. The solution was cooled to 0 00 and sodium triacetoxyborohydride (9.27 g,43.7 mmol) was added portion-wise. The reaction stirred overnight while slowly warming toroom temperature. The reaction mixture was concentrated under reduced pressure and theresulting residue was diluted with DCM washed sequentially with saturated sodiumbicarbonate, water and saturated sodium chloride. The organic layer was dried over Na2SO4, filtered and concentrated to dryness. The crude material was purified by silica gel chromatography (DCM/EtOAc/MeOH) to afford 1 -tert-butyl 2-methyl (2S,4R)-4-[2-(tert- butoxycarbonylamino)ethylamino]pyrrolidine- 1 ,2-dicarboxylate (Intermediate 72, 4.77 g, 42%yield) as a colorless oil. 1H NMR (500MHz, DMSO-d6) 51.25- 1.48 (20H, m), 1.84-2.07 (3H,m), 2.88-2.98 (2H, m), 3.02-3.17 (1H, m), 3.17-3.27 (1H, m), 3.40-3.51 (1H, m), 3.64(3H,s), 4.14-4.24 (1 H, m), 6.63-6.74 (1 H, m); m/z: (ESj [M+H] = 388.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;